ACCESS Newswire
22 Nov 2022, 19:01 GMT+10
OXFORD, UK / ACCESSWIRE / November 22, 2022 / IntraBio Inc announced today that it has enrolled 100% of the target number of patients for its multinational pivotal trial, IB1001-301, 'Effects of N-Acetyl-L-Leucine on Niemann-Pick disease type C (NPC): A Phase III, randomized, placebo-controlled, double-blind, crossover study'.
Enrollment for IB1001-301 commenced in September 2022, and patients were screened at trial sites in Australia, the Czech Republic, Germany, the Netherlands, Slovakia, Switzerland, the United Kingdom, and the United States. To increase the study's power, IntraBio plans to 'over enroll' the trial by over 125% and expects this additional recruitment to be completed by year-end. Data readout is anticipated before the end of the second quarter 2023.
About IB1001-301
IB1001-301 investigates N-Acetyl-L-Leucine (IB1001) for both the symptomatic and long-term neuroprotective effect of treatment of Niemann-Pick disease Type C (NPC), with the primary endpoint based on the Scale for the Assessment and Rating of Ataxia. The study was designed in consultation with neurologists engaged in the treatment of NPC and NPC patient organizations. The study has been designed to support a label for the chronic treatment of NPC symptoms.
IB1001 Development Program / Approval Pathway
This pivotal trial was also designed in consultation with both the US Food and Drug Administration (FDA) and the European Medicine Agency (EMA) to support an accelerated approval pathway for IB1001. Upon approval of IB1001, IntraBio would be eligible for a 'priority review voucher' by the FDA, which can be used or sold, with all sales of these vouchers in the past 2 years over $100 million each. IntraBio is also Phase III ready for three other disease indications.
About IntraBio
IntraBio Inc is a biopharmaceutical company with a late-stage drug pipeline, including novel treatments for common and rare neurodegenerative diseases. IntraBio's platform technologies result from decades of research and investment at premier universities and institutions worldwide. Its clinical programs leverage the expertise in lysosomal function and intracellular calcium signalling of its scientific founders from the University of Oxford and the University of Munich.
IntraBio's management team and consultants have a successful track record of drug development in the USA and Europe. This team translates innovative scientific research in the fields of lysosomal biology, autophagy, and neurology into novel drugs for a broad spectrum of genetic and neurodegenerative diseases so to significantly improve the lives of patients.
IntraBio Inc is a US corporation with its principal operations in Oxford, United Kingdom.
For further information please contact:
Cass Fields
[email protected]
www.intrabio.com
SOURCE: IntraBio Inc.
Get a daily dose of Illinois Intelligencer news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Illinois Intelligencer.
More InformationOTTAWA, Canada: With Canada Post struggling to maintain operations amid labour unrest, rivals like FedEx and UPS are stepping in to...
Dhaka [Bangladesh], July 12 (ANI): The three-day second-round tariff talks between Bangladesh and the United States have ended without...
Washington, DC [US], July 12 (ANI): The Beatles legend Paul McCartney is hitting the road again. The singer-songwriter has announced...
New Delhi [India], July 12 (ANI): A preliminary investigation into the Air India flight AI171 crash has revealed that just seconds...
Hyderabad (Telangana) [India], July 12 (ANI): Telangana Chief Minister Revanth Reddy has said that the spirit of Telangana is similar...
The Pentagon abruptly suspended the shipments in early July, citing a need to audit remaining stockpiles Ukrainian President Vladimir...
ATLANTA, Georgia: The United States is facing its worst measles outbreak in more than three decades, with 1,288 confirmed cases so...
In the past month alone, 23 Israeli soldiers have been killed in Gaza—three more than the number of remaining living hostages held...
LONDON, U.K.: At least 13 people are believed to have taken their own lives as a result of the U.K.'s Post Office scandal, in which...
WASHINGTON, D.C.: Travelers at U.S. airports will no longer need to remove their shoes during security screenings, Department of Homeland...
WASHINGTON, D.C.: An elaborate impersonation scheme involving artificial intelligence targeted senior U.S. and foreign officials in...
SLUBICE, Poland: Poland reinstated border controls with Germany and Lithuania on July 7, following Germany's earlier reintroduction...